Company Filing History:
5 out of 260 
5 out of 7 
1 out of 1 Years Active: 2013-2021
Title: **Innovative Contributions of Thong-Gyu Jin in Treating Hunter Syndrome**
Introduction
Thong-Gyu Jin, based in Seoul, South Korea, is a renowned inventor with a significant portfolio of innovations. He holds six patents, primarily focused on advancements in medical treatments for rare diseases, particularly Hunter Syndrome. His work emphasizes the importance of developing effective therapeutic methods for complex disorders.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Methods and compositions for treating Hunter Syndrome." This invention encompasses compositions and methods designed for the central nervous system delivery of Idursulfase-beta. It aims for an effective treatment of Hunter Syndrome by alleviating symptoms in not just the brain and spinal cord, but also in peripheral tissues such as the heart, liver, spleen, lung, and kidneys. Another notable patent, "Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof," presents a new composition of recombinant iduronate-2-sulfatase (IDS). This formulation exhibits a different glycosylation pattern and formylglycine content compared to existing treatments, like ELAPRASE®; thus, it promises superior pharmaceutical efficacy and safety for the therapy of Hunter Syndrome.
Career Highlights
Thong-Gyu Jin has made substantial contributions to the field of biotechnology through his innovative research and patent developments. His career features significant positions in esteemed companies such as the Green Cross Corporation and Medigenebio Corporation. These organizations have provided him with the platform to advance his research and bring his innovative ideas to fruition.
Collaborations
Throughout his career, Jin has collaborated with esteemed professionals, including Yong-Chul Kim and Yo Kyung Chung. These collaborations have been vital in enriching his research and expanding the scope of his inventions, showcasing the power of teamwork in tackling complex medical challenges.
Conclusion
Thong-Gyu Jin stands out as a prominent inventor in the field of biotechnology, particularly in the treatment of rare diseases like Hunter Syndrome. His six patents reflect a dedicated commitment to innovation and a pursuit of effective therapies that can significantly improve patient outcomes. His work continues to inspire advancements in medical science, providing hope to countless individuals affected by these challenging conditions.